The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.
about
Fetal alcohol-spectrum disorders: identifying at-risk mothersCost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in ChildrenA comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis.The validity of phosphatidylethanol in dried blood spots of newborns for the identification of prenatal alcohol exposureEliciting parental support for the use of newborn blood spots for pediatric research.Plasma miRNA Profiles in Pregnant Women Predict Infant Outcomes following Prenatal Alcohol Exposure.The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatmentStability of Phosphatidylethanol in Dry Blood Spot CardsMaternal and neonatal plasma microRNA biomarkers for fetal alcohol exposure in an ovine modelSpot them in the spot: analysis of abused substances using dried blood spots.Progress in monitoring alcohol consumption and alcohol abuse by phosphatidylethanol.Ethanol metabolites: their role in the assessment of alcohol intake.Biomarkers for the Detection of Prenatal Alcohol Exposure: A Review.Determination of fatty acid ethyl esters in dried blood spots by LC-MS/MS as markers for ethanol intake: application in a drinking study.Prevalence of Prenatal Alcohol Exposure in the State of Texas as Assessed by Phosphatidylethanol in Newborn Dried Blood Spot Specimens.Quantification of phosphatidylethanol 16:0/18:1, 18:1/18:1, and 16:0/16:0 in venous blood and venous and capillary dried blood spots from patients in alcohol withdrawal and control volunteers.Placental Proteomics Reveal Insights into Fetal Alcohol Spectrum Disorders.Recidivism Risk of Repeat Intoxicated Drivers Monitored with Alcohol Biomarkers
P2860
Q26738661-94965C97-CF4B-41AB-917D-906997DB7DA4Q28554982-473DC741-E444-44CF-88C7-48EE3DAE4BB9Q35141199-AB21FAA1-FDDF-4F70-A6BC-0DD3230B0D53Q35546771-BF3F4A4F-6666-456F-A4DE-ACB69E807367Q35914778-B1219F62-3FCE-49D2-858C-B09B4CE71EC1Q36187308-8B63E1DF-7247-4729-8FD3-6877C5BF8B50Q36373210-C338B1A6-0BD7-477B-BEA0-10ED689F343CQ36794751-D9D21586-8A22-4FEC-8A51-9D14FFCC8111Q37722648-27212563-EBED-4130-BE3E-EE0593B7349DQ38266512-9677D54A-4D2D-4510-84D2-D8D68CF151F4Q38266518-840AF53C-CCCB-4E30-B880-A776298F5F5AQ38581962-70D60DDD-C6A5-4958-AD93-F2E510A3B989Q39093612-4B93D2AD-9E25-4717-869E-10DD2BF13202Q39927814-DC5EAF3F-F523-4CF7-803C-F89AC4DA912AQ40452219-85CB40B1-8B0F-4D62-AB3B-6CBC43D55EC6Q46635096-019FD18E-0666-4840-A9CC-C6D0A4326FA6Q48104037-7ECB659A-7037-4F8A-8B11-D2A92B9B97D1Q58258061-ADE6B188-FDCC-4A2A-A106-3B8B78C883FA
P2860
The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The feasibility and cost of ne ...... lethanol in dried blood spots.
@en
type
label
The feasibility and cost of ne ...... lethanol in dried blood spots.
@en
prefLabel
The feasibility and cost of ne ...... lethanol in dried blood spots.
@en
P2093
P2860
P356
P1476
The feasibility and cost of ne ...... lethanol in dried blood spots.
@en
P2093
Chelsea Goff
Daniel D Savage
Dennis W Raisch
Lawrence Leeman
Ludmila N Bakhireva
Mahek Garg
Renate D Savich
Robert D Annett
Sandra Cano
P2860
P304
P356
10.1111/ACER.12045
P577
2013-02-19T00:00:00Z